People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellphire, Inc. | — | Biotechnology | Seed | $5.0M | $6.7M | 2023 |
Thomas Dubin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Dubin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Gaffney | 1 | 3 |
| James Peake | 1 | 2 |
| Randall Stanicky | 1 | 2 |
| Pamela Conley | 1 | 1 |
| Derek Woods | 1 | 1 |
| Rob Woods | 1 | 1 |
| David Hirsh | 1 | 1 |
| Cristiane Wolfe | 1 | 1 |
| Angela Howerton | 1 | 1 |
| Rafael Jorda | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.